Learn more

NUCLEA BIOTECHNOLOGIES INC

Overview
  • Total Patents
    41
  • GoodIP Patent Rank
    167,334
About

NUCLEA BIOTECHNOLOGIES INC has a total of 41 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are CHENG SHULING, BEIJING JIUQIANG BIOTECHNOLOGY CO LTD and TOWNS KK.

Patent filings per year

Chart showing NUCLEA BIOTECHNOLOGIES INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Muraca Patrick J 41
#2 Xu Ying 5
#3 Tam Sun W 5
#4 Zhang Yunhui 2
#5 Drescher Christopher S 2

Latest patents

Publication Filing date Title
US2015309034A1 Biomarker panel for prediction of recurrent colon cancer
WO2015026893A1 Predictive biomarkers for metabolic syndrome
WO2015026909A2 Msia-srm assay for biomarker analysis
US2014371087A1 Mixed format microarrays
US2013338027A1 Predictive Markers For Cancer and Metabolic Syndrome
US2015133342A1 Mrm-ms signature assay
WO2013096534A1 Congestive heart failure biomarkers
CA2852757A1 Predictive biomarkers for breast cancer
WO2012142349A2 Gene expression profile for therapeutic response to vegf inhibitors
EP2599793A1 Anti-phospho-akt antibodies
US2009111124A1 Kinase peptides and antibodies